A Meta-Analysis of Smoking Cessation Interventions With Individuals in Substance Abuse Treatment or Recovery.

Prochaska, Judith J.; Delucchi, Kevin; Hall, Sharon M.

doi:10.1037/0022-006x.72.6.1144

Cited by 498 publications

(473 citation statements)

References 76 publications

Supporting

Mentioning

436

Contrasting

Unclassified

Order By: Relevance

“…Although smoking interventions started early in residential treatment have been shown to affect abstinence rates, these effects are largely short term (Joseph, Willenbring, Ngent, & Nelson, 2004). Studies examining the effectiveness of smoking cessation treatment in drug treatment show short-term (6-month) reductions in cigarette use, but do not show long-term (18-month) effects (Prochaska et al, 2004). It is unclear to what extent treatment staff members are aware of these findings and how much this lack of evidence influences staff attitudes.…”

Section: Study Limitationsmentioning

confidence: 75%

“…Some research studies demonstrate that smoking cessation interventions improve long-term abstinence from alcohol or drugs, but not tobacco use (Bobo, McIlvain, Lando, Walker, & Leed-Kelly, 1998;Prochaska, Delucchi, & Hall, 2004). Although smoking interventions started early in residential treatment have been shown to affect abstinence rates, these effects are largely short term (Joseph, Willenbring, Ngent, & Nelson, 2004).…”

Section: Study Limitationsmentioning

confidence: 99%

See 1 more Smart Citation

Attitudes toward the integration of smoking cessation treatment into drug abuse clinics

Fuller

Guydish

Tsoh

et al. 2007

Journal of Substance Abuse Treatment

103

110

View full text Add to dashboard Cite

This article examines the variables associated with the presence of smoking cessation interventions in drug abuse treatment units, as well as staff attitudes toward the integration of smoking cessation services as a component of care. Surveys were administered to 106 organizations, 348 treatment clinics, and 3,786 employees in agencies that participated in the National Drug Abuse Treatment Clinical Trials Network. Organizational factors, attributes of the treatment setting, and staff attitudes toward smoking cessation treatment were assessed. Use of smoking cessation interventions was associated with the number of additional services offered at clinics, residential detoxification services, and attitudes of the staff toward smoking cessation treatment. Staff attitudes toward integrating smoking cessation services in drug treatment were influenced by the number of pregnant women admitted, the number of ancillary services provided, the attitudes of staff toward evidence-based practices, and whether smoking cessation treatment was offered as a component of care.

show abstract

Section: Study Limitationsmentioning

confidence: 75%

Section: Study Limitationsmentioning

confidence: 99%

Attitudes toward the integration of smoking cessation treatment into drug abuse clinics

Fuller

Guydish

Tsoh

et al. 2007

Journal of Substance Abuse Treatment

103

110

View full text Add to dashboard Cite

show abstract

“…32 However, a substantial body of evidence suggests that smoking cessation with patients with mental illness or addiction does not harm, and in some cases actually improves, treatment outcomes. 33 A meta-analysis conducted by Prochaska and colleagues found that smoking cessation during SUD treatment was associated with a 25% increased likelihood of long term drug and alcohol abstinence. Smoking cessation support from behavioral health providers and addiction specialists is needed to make lasting change and reduce smoking rates in this high risk patient population.…”

Section: Discussionmentioning

confidence: 99%

Smoking Among Pregnant Women in Outpatient Treatment for Opioid Dependence: A Qualitative Inquiry

Fallin

Miller

Ashford

2016

NICTOB

View full text Add to dashboard Cite

Introduction: Smoking during pregnancy is a major public health issue, contributing to adverse health outcomes. The vast majority of women with substance use disorders smoke during the perinatal period. Medication Assisted Treatment (MAT) is the standard of care for women using opioids during pregnancy. The majority of women engaged in MAT (88%-95%) report smoking. The purposes of this study were to describe: (1) facilitators and barriers to engaging in tobacco treatment among pregnant, opioid dependent women receiving MAT; and (2) strategies to tailor tobacco treatment interventions with this population. Methods: Two semi-structured focus groups lasting approximately 45 minutes each were conducted with 22 women engaged in MAT. Focus groups were recorded, transcribed and analyzed in MAXQDA using content analysis. Results: Participants reported: (1) desire to quit smoking for themselves and their children; (2) aversion to smoking; (3) a turning point in their lives from being pregnant and entering MAT; (4) nicotine dependence; (5) smoking as a way to cope with stress; (6) coping with dual dependencies; (7) past experiences with stopping smoking due to smoking restrictions; (8) perceived lack of success with nicotine replacement therapy or other tobacco treatment medications; and (9) the need for intensive environmental support for quit attempts. Conclusions: Participants were motivated to quit smoking, but faced multiple complex barriers. Integrating tobacco treatment into the psychosocial services offered in conjunction with MAT would allow a healthcare provider to offer tailored tobacco treatment in a supportive environment. Implications: Results of this qualitative study include facilitators and barriers to engaging in tobacco treatment among pregnant, opioid dependent women receiving MAT, as well as strategies to tailor tobacco treatment interventions for this population. In-depth knowledge of the complex barriers facing this patient population can be used to inform tailored tobacco treatment services that can be integrated into clinics providing MAT.

show abstract

“…The bulk of the studies have been conducted among smokers in substance abuse treatment (e.g., Prochaska, Delucchi, & Hall, 2004). Only a few studies integrate smoking cessation treatment into other psychiatric settings, such as posttraumatic stress disorder treatment (McFall et al, 2005) or treatment for depression .…”

Section: Novel Channels For Treatment Deliverymentioning

confidence: 99%

Smoking cessation: Next steps for special populations research and innovative treatments.

Borrelli

2010

Journal of Consulting and Clinical Psychology

View full text Add to dashboard Cite

Objective:The current introductory article provides the rationale for the special section on understudied smokers and innovative treatments. This article proposes a definition of "special populations" of smokers, outlines a priori criteria by which to judge whether an intervention should be adapted for these smokers, and delineates a process by which cultural adaptation of an intervention can be achieved. Next steps for innovative, theory-based treatments with special populations and with general populations of smokers are discussed. Method: Special populations of smokers are defined as having (a) Ͼ10% higher smoking prevalence than the general population of smokers, (b) disproportionate tobacco-related health disparities, (c) less access to treatments, and (d) a lack of prospective, longitudinal treatment trials. Results: Cultural adaptation of evidenced-based treatments (EBTs) for underserved smokers should be applied more widely, outside the bounds of race and ethnicity, but also judiciously, following several a priori criteria. Cultural adaptation may be justified if the target population differs from the general population in (a) rates and patterns of smoking, (b) burden of tobacco-related health diseases, (c) predictors of smoking behavior, (d) risk factors for treatment failure, (e) protective factors that facilitate quitting, (f) treatment engagement, (g) treatment response, and (h) perceived social validity of the EBT. Once these criteria are met, four phases of cultural adaptation of an EBT for the target population are proposed. Innovative treatments need to be developed that use novel channels and linkages between channels; test novel theories or build on mechanisms research to more accurately pinpoint targets of change; and increase consumer demand for EBTs. Conclusion: The process of cultural adaptation should be thoughtfully conducted with a priori definitions and criteria as well as standardized processes. Coupled with innovative, theory-based treatments, these considerations could help to jump-start stalled smoking cessation rates. Decreasing the prevalence of smoking will take a multitarget, multichannel, multimethod approach at different levels of social strata: individuals (i.e., address smoker heterogeneity, develop innovative treatments), groups (i.e., target populations with higher than average smoking prevalence; eradicate disparities in treatment access, engagement, and effectiveness), cultural/societal level (i.e., increase frequency and effectiveness of mass media campaigns, create greater consumer demand for evidenced-based treatments [EBTs]), health care systems and insurers (i.e., increase counseling and reimbursement, reduce out-of-pocket costs to smokers who want to quit), and government (i.e., increase taxation, expand smoke-free laws, increase funding of state quit lines).Although all of these factors are critical to jump-starting stalled smoking cessation rates, in January 2009 the Journal of Consulting and Clinical Psychology initiated a call for papers focusing on the first t...

show abstract

A Meta-Analysis of Smoking Cessation Interventions With Individuals in Substance Abuse Treatment or Recovery.

Cited by 498 publications

References 76 publications

Attitudes toward the integration of smoking cessation treatment into drug abuse clinics

Attitudes toward the integration of smoking cessation treatment into drug abuse clinics

Smoking Among Pregnant Women in Outpatient Treatment for Opioid Dependence: A Qualitative Inquiry

Smoking cessation: Next steps for special populations research and innovative treatments.

Contact Info

Product

Resources

About